Japan to demand more clinical data in product reviews; joins single-audit pilot
This article was originally published in Clinica
Executive Summary
Medical device and drug companies will be required to submit more in-depth data to get product marketing approval in Japan, as the country’s Pharmaceuticals and Medical Devices Agency plans to introduce in a few years’ time "advanced" product evaluations by a new Regulatory Science Centre (RSC).